SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-052513
Filing Date
2006-08-08
Accepted
2006-08-08 16:16:56
Documents
8
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-15260_110q.htm 10-Q 867552
2 AM#1 TO LICENSE AGMT a06-15260_1ex10d1.htm EX-10.1 23238
3 2004 STOCK INCENTIVE a06-15260_1ex10d2.htm EX-10.2 65153
4 2000 EMPLOYEE STOCK PURCHASE a06-15260_1ex10d3.htm EX-10.3 83379
5 CEO - 302 a06-15260_1ex31d1.htm EX-31.1 10834
6 CFO - 302 a06-15260_1ex31d2.htm EX-31.2 10864
7 CEO - 906 a06-15260_1ex32d1.htm EX-32.1 6897
8 CFO - 906 a06-15260_1ex32d2.htm EX-32.2 7493
  Complete submission text file 0001104659-06-052513.txt   1076780
Mailing Address
Business Address 8 CAMPUS DRIVE PARSIPPANY NJ 07054 973-656-1616
MEDICINES CO /DE (Filer) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31191 | Film No.: 061013364
SIC: 2834 Pharmaceutical Preparations